TrialDiabetes care2014

Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes.

Julio Rosenstock et al.PubMed ↗Publisher ↗

No numbers read from the abstract.